Annual Gross Margin
76.80%
-2.10%-2.66%
31 December 2023
Summary:
Halozyme Therapeutics annual gross profit margin is currently 76.80%, with the most recent change of -2.10% (-2.66%) on 31 December 2023. During the last 3 years, it has fallen by -4.84% (-5.93%). HALO annual gross margin is now -22.85% below its all-time high of 99.54%, reached on 31 December 2011.HALO Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
82.96%
+0.08%+0.10%
30 September 2024
Summary:
Halozyme Therapeutics quarterly gross profit margin is currently 82.96%, with the most recent change of +0.08% (+0.10%) on 30 September 2024. Over the past year, it has increased by +5.69% (+7.36%). HALO quarterly gross margin is now -17.00% below its all-time high of 99.95%, reached on 30 September 2011.HALO Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +7.4% |
| 3 y3 years | -5.9% | +5.2% |
| 5 y5 years | +0.1% | +20.4% |
HALO Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.3% | at low | -4.0% | +11.2% |
| 5 y | 5 years | -17.7% | +0.1% | -9.3% | +60.5% |
| alltime | all time | -22.9% | +114.8% | -17.0% | +4613.6% |
Halozyme Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 82.96%(+0.1%) |
| June 2024 | - | 82.88%(-3.1%) |
| Mar 2024 | - | 85.54%(+10.7%) |
| Dec 2023 | 76.80%(-2.7%) | 77.27%(+3.6%) |
| Sept 2023 | - | 74.62%(-3.5%) |
| June 2023 | - | 77.35%(-1.2%) |
| Mar 2023 | - | 78.31%(+2.0%) |
| Dec 2022 | 78.90%(-3.4%) | 76.79%(-0.7%) |
| Sept 2022 | - | 77.36%(-0.5%) |
| June 2022 | - | 77.72%(-10.1%) |
| Mar 2022 | - | 86.42%(+9.6%) |
| Dec 2021 | 81.64%(-2.6%) | 78.84%(-6.1%) |
| Sept 2021 | - | 83.95%(+1.0%) |
| June 2021 | - | 83.13%(+4.5%) |
| Mar 2021 | - | 79.53%(+1.4%) |
| Dec 2020 | 83.79%(+9.2%) | 78.41%(-14.3%) |
| Sept 2020 | - | 91.48%(+2.1%) |
| June 2020 | - | 89.61%(+16.1%) |
| Mar 2020 | - | 77.18%(+12.0%) |
| Dec 2019 | 76.76%(-17.8%) | 68.91%(+33.3%) |
| Sept 2019 | - | 51.69%(-45.7%) |
| June 2019 | - | 95.21%(+3.7%) |
| Mar 2019 | - | 91.84%(+1.3%) |
| Dec 2018 | 93.33%(+3.5%) | 90.67%(-7.1%) |
| Sept 2018 | - | 97.55%(-0.1%) |
| June 2018 | - | 97.63%(+8.3%) |
| Mar 2018 | - | 90.11%(-6.2%) |
| Dec 2017 | 90.16%(+16.5%) | 96.05%(+10.5%) |
| Sept 2017 | - | 86.93%(+13.0%) |
| June 2017 | - | 76.92%(+3.3%) |
| Mar 2017 | - | 74.49%(-6.3%) |
| Dec 2016 | 77.36%(-1.3%) | 79.48%(+11.4%) |
| Sept 2016 | - | 71.32%(-5.0%) |
| June 2016 | - | 75.08%(-8.1%) |
| Mar 2016 | - | 81.74%(-2.5%) |
| Dec 2015 | 78.35%(+12.2%) | 83.86%(+19.4%) |
| Sept 2015 | - | 70.26%(-13.5%) |
| June 2015 | - | 81.23%(+24.6%) |
| Mar 2015 | - | 65.21%(-18.2%) |
| Dec 2014 | 69.83% | 79.76%(+23.1%) |
| Sept 2014 | - | 64.80%(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | 67.78%(+25.8%) |
| Mar 2014 | - | 53.87%(-24.8%) |
| Dec 2013 | 88.60%(-9.1%) | 71.68%(-25.1%) |
| Sept 2013 | - | 95.73%(+5.1%) |
| June 2013 | - | 91.12%(-2.8%) |
| Mar 2013 | - | 93.76%(-3.3%) |
| Dec 2012 | 97.42%(-2.1%) | 97.00%(+1.3%) |
| Sept 2012 | - | 95.75%(-2.5%) |
| June 2012 | - | 98.16%(-0.9%) |
| Mar 2012 | - | 99.05%(+1.4%) |
| Dec 2011 | 99.54%(+7.3%) | 97.67%(-2.3%) |
| Sept 2011 | - | 99.95%(+0.7%) |
| June 2011 | - | 99.23%(-0.6%) |
| Mar 2011 | - | 99.84%(+32.9%) |
| Dec 2010 | 92.77%(-5.1%) | 75.12%(-24.7%) |
| Sept 2010 | - | 99.79%(+2.5%) |
| June 2010 | - | 97.40%(-2.4%) |
| Mar 2010 | - | 99.84%(+2.4%) |
| Dec 2009 | 97.72%(+1.6%) | 97.52%(+0.9%) |
| Sept 2009 | - | 96.61%(-0.2%) |
| June 2009 | - | 96.84%(-3.0%) |
| Mar 2009 | - | 99.85%(+4.2%) |
| Dec 2008 | 96.21%(+2.7%) | 95.84%(+1.2%) |
| Sept 2008 | - | 94.69%(-2.8%) |
| June 2008 | - | 97.41%(-0.5%) |
| Mar 2008 | - | 97.94%(+0.1%) |
| Dec 2007 | 93.67%(+68.8%) | 97.82%(+4.4%) |
| Sept 2007 | - | 93.69%(+4.9%) |
| June 2007 | - | 89.34%(-1.4%) |
| Mar 2007 | - | 90.59%(+0.3%) |
| Dec 2006 | 55.49%(-6.2%) | 90.29%(+5030.1%) |
| Sept 2006 | - | 1.76%(-98.0%) |
| June 2006 | - | 86.18%(+25.5%) |
| Mar 2006 | - | 68.67%(+9.6%) |
| Dec 2005 | 59.15%(+65.4%) | 62.67%(+3.3%) |
| Sept 2005 | - | 60.65%(+12.3%) |
| June 2005 | - | 54.00%(-27.0%) |
| Dec 2002 | - | 74.01%(-5.6%) |
| Sept 2002 | - | 78.36%(+1626.0%) |
| June 2002 | - | 4.54%(-95.0%) |
| Mar 2002 | - | 90.32% |
| Dec 2001 | 35.76% | - |
FAQ
- What is Halozyme Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly gross margin year-on-year change?
What is Halozyme Therapeutics annual gross profit margin?
The current annual gross margin of HALO is 76.80%
What is the all time high annual gross margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual gross profit margin is 99.54%
What is Halozyme Therapeutics quarterly gross profit margin?
The current quarterly gross margin of HALO is 82.96%
What is the all time high quarterly gross margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly gross profit margin is 99.95%
What is Halozyme Therapeutics quarterly gross margin year-on-year change?
Over the past year, HALO quarterly gross profit margin has changed by +5.69% (+7.36%)